Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Miles

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancers|December 11, 2022
Determination of Interactive States of Immune Checkpoint Regulators in Lung Metastases after Radiofrequency AblationJames Miles, Isabelle Soubeyran, Florence Marliot, et al.
BBA Clinical|January 4, 2018
Time resolved amplified FRET identifies protein kinase B activation state as a marker for poor prognosis in clear cell renal cell carcinomaJames Miles, Christopher J Applebee, Pierre Leboucher, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
<i>Datura</i> quids at Pinwheel Cave, California, provide unambiguous confirmation of the ingestion of hallucinogens at a rock art siteDavid W Robinson, Kelly Brown, Moira McMenemy, et al.
Cancer Research|August 29, 2020
High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 TreatmentLissete Sánchez-Magraner, James Miles, Claire L Baker, et al.
Gastroenterology|July 1, 2021
Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation CohortsMichele Bortolomeazzi, Mohamed Reda Keddar, Lucia Montorsi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2023
Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non-Small-Cell Lung CancerLissete Sánchez-Magraner, Juan Gumuzio, James Miles, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancers|December 11, 2022
Determination of Interactive States of Immune Checkpoint Regulators in Lung Metastases after Radiofrequency AblationJames Miles, Isabelle Soubeyran, Florence Marliot, et al.
BBA Clinical|January 4, 2018
Time resolved amplified FRET identifies protein kinase B activation state as a marker for poor prognosis in clear cell renal cell carcinomaJames Miles, Christopher J Applebee, Pierre Leboucher, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
<i>Datura</i> quids at Pinwheel Cave, California, provide unambiguous confirmation of the ingestion of hallucinogens at a rock art siteDavid W Robinson, Kelly Brown, Moira McMenemy, et al.
Cancer Research|August 29, 2020
High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 TreatmentLissete Sánchez-Magraner, James Miles, Claire L Baker, et al.
Gastroenterology|July 1, 2021
Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation CohortsMichele Bortolomeazzi, Mohamed Reda Keddar, Lucia Montorsi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2023
Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non-Small-Cell Lung CancerLissete Sánchez-Magraner, Juan Gumuzio, James Miles, et al.
Pageof 2